期刊文献+

临床药师对儿科抗病毒药合理应用干预的研究 被引量:10

Pharmacists' Intervention on Rational Use of Antiviral Drugs in Paediatrics
原文传递
导出
摘要 目的:探讨临床药师对儿科抗病毒药合理应用干预的影响。方法:采用回顾性调查方法,调取我院2005年3月(干预前)及2006年3月(干预后)所有出院儿科患儿住院病历,对其应用抗病毒药的合理性进行分析。结果:干预前与干预后抗病毒药应用率分别为64.14%、60.14%;抗病毒药不当应用率分别为22.58%、4.49%;抗病毒药与抗菌药物合用率分别为61.37%、56.08%;抗病毒药平均费用分别为76.94、23.71元。结论:通过药师提供有效的药学服务和干预,可明显改善儿科抗病毒药的合理应用。 OBJECTIVE: To discuss the influence of clinical pharmacist' intervention on the rational use of antiviral drugs in Pediatrics. METHODS: A retrospective study was conducted in which all paediatric case histories of patients who discharged form hospital in Mar. 2005 (before intervention) and in Mar. 2006 (after intervention) were analyzed in respect of the rationality of drug use. RESULTS: The rate of using antiviral drugs in Paediatric inpatients before intervention was 60.14% versus 64.14% after intervention; the rates of irrational use of anti viral drugs were 4.49% and 22.58%, respectively; the rates of antiviral drugs used in combination with antibiotics were 56.08% and 61.37% respectively; and the average costs for antiviral drugs per capita were 23.71yuan and 76.94 yuan, respectively before and after intervention. CONCLUSION: Theeffective pharmaceutical care and intervention provided by clinical pharmacists help to improve the rational drug use level of antiviral drugs in paediatric patients.
出处 《中国药房》 CAS CSCD 北大核心 2008年第17期1353-1355,共3页 China Pharmacy
基金 深圳市科技计划项目(医疗卫生类)(200703223)
关键词 临床药师 药学服务 抗病毒药 合理用药 Clinical pharmacist Pharmaceutical care Antiviral drugs Rational drug use
  • 相关文献

参考文献4

二级参考文献21

  • 1李亚男,方峰.儿童乙型病毒性肝炎的治疗进展[J].国外医学(儿科学分册),2005,32(4):226-229. 被引量:7
  • 2Balfour HH. Drug therapy: Antiviral drugs. N Engl J Med, 1999;340:1255 - 1268.
  • 3Cohen JI, Brunell PA, Straus SE, et al. Recent advances invaricellazoster virus infection. Ann Intern Med, 1999;130:922-932.
  • 4Furman PA, St Clair MH, Spector T. Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase.J Biol Chem, 1984;259:9575 -9579.
  • 5de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother,1983; 12(Suppl. B):S29 - S37.
  • 6Bodsworth NJ, Crooks RJ, Borelli S, et al. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes:a randomised, double-blind clinical trial. Genitourin Med, 1997;73:110-116.
  • 7Crumpacker CS. Ganciclovir. N Engl J Med, 1996;335:721 - 729.
  • 8Earnshaw DL,Bacon TH, Darlison S J, et al. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV- 1 ), HSV-2, and varicella-zoster virus. Antimicrob Agents Chemother, 1992;36:2747 - 2757.
  • 9Sacks SL, Aoki FY, Diaz-Mitoma F, et al. Patient-initiated, twicedaily oral famciclovir for early recurrent genital herpes:a rando mized, double-blind multicenter trial. JAMA, 1996;276:44--49.
  • 10Oberg B. Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther, 1989;40:213 - 285.

共引文献18

同被引文献98

引证文献10

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部